BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24718007)

  • 1. Nasal T cell lymphoma: a rare entity.
    Kazi M; Ikram M; Junaid M
    J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S50-1. PubMed ID: 24718007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.
    Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A
    J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
    Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
    Liu QF; Wang WH; Wang SL; Liu YP; Huang WT; Lu N; Zhou LQ; Ouyang H; Jin J; Li YX
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):806-13. PubMed ID: 24495590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
    Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine needle aspiration cytology of CD56-positive natural killer/T-cell lymphoma of soft tissue.
    Cho EY; Gong G; Khang SK; Kang YK; Huh J
    Cancer; 2002 Dec; 96(6):344-50. PubMed ID: 12478682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nasal NK cell lymphoma with hemophagocytic syndrome developed tumor lysis syndrome after CHOP therapy].
    Sawada M; Yamada T; Tsurumi H; Moriwaki H
    Rinsho Ketsueki; 2002 Nov; 43(11):988-92. PubMed ID: 12508484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic analysis of 62 cases of nasal NK/T-cell lymphoma].
    Xiao J; Wang SS; Huang Y; Chen LK; Guan ZZ; Huang HQ; Xia ZJ; Xu RH; Lin TY
    Ai Zheng; 2006 Sep; 25(9):1173-7. PubMed ID: 16965665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel treatment for early-stage nasal natural killer/T-cell lymphoma: intra-maxillary arterial infusion chemotherapy with concomitant radiotherapy.
    Takahara M; Nagato T; Kishibe K; Ueda S; Komabayashi Y; Yamashina M; Takahashi K; Harabuchi Y
    Hematol Oncol; 2017 Jun; 35(2):158-162. PubMed ID: 26563973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma].
    Yong W; Zheng W; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):773-5. PubMed ID: 11798962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients.
    Akiyama T; Okino T; Konishi H; Wani Y; Notohara K; Tsukayama C; Tsunoda T; Tasaka T; Masaki Y; Sugihara T; Sadahira Y
    Pathol Int; 2008 Oct; 58(10):626-34. PubMed ID: 18801082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity.
    Wang B; Lu JJ; Ma X; Guo Y; Lu H; Hong X; Li J
    Leuk Lymphoma; 2007 Feb; 48(2):396-402. PubMed ID: 17325902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of concurrent chemoradiotherapy for stage I nasal NK/T cell lymphoma: a report of two cases.
    Niibe Y; Hayakawa K; Kitano M; Ishiyama H; Nakayama M; Yao K; Okamoto M
    Anticancer Res; 2005; 25(6C):4403-6. PubMed ID: 16334116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.
    Yong W; Zheng W; Zhu J; Zhang Y; Wei Y; Wang X; Lin N; Xie Y; Xu B; Li J
    Hematol Oncol; 2006 Mar; 24(1):28-32. PubMed ID: 16323259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer T-cell lymphoma of the tongue.
    Cho KJ; Cho SG; Lee DH
    Ann Otol Rhinol Laryngol; 2005 Jan; 114(1 Pt 1):55-7. PubMed ID: 15697163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated nasal-type natural killer/T-cell lymphoma in a child: a case report.
    Pellier I; N'Golet L; Rachieru P; Rousselet MC; Geneviève F; Moles MP; Hermine O; Rialland X
    J Pediatr Hematol Oncol; 2009 May; 31(5):362-6. PubMed ID: 19415021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon.
    Wong KF; Chan JK; Cheung MM; So JC
    Am J Clin Pathol; 2001 Feb; 115(2):266-70. PubMed ID: 11211616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective survey.
    Pagano L; Gallamini A; Trapè G; Fianchi L; Mattei D; Todeschini G; Spadea A; Cinieri S; Iannitto E; Martelli M; Nosari A; Bona ED; Tosti ME; Petti MC; Falcucci P; Montanaro M; Pulsoni A; Larocca LM; Leone G;
    Ann Oncol; 2006 May; 17(5):794-800. PubMed ID: 16497823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term survival after nasal NK/T cell lymphoma].
    Rajnics P; Krenács L; Kenéz A; Járay Z; Bagdi E; Demeter J
    Orv Hetil; 2008 Apr; 149(17):801-5. PubMed ID: 18426762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type.
    Wang B; Li XQ; Ma X; Hong X; Lu H; Guo Y
    Am J Hematol; 2008 Oct; 83(10):795-9. PubMed ID: 18756548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.